Paxlovid COVID Treatment Most Beneficial for Unvaccinated People with Risk Factors. Others May Not Need It
Briefly

from www.scientificamerican.com8 months ago
A new study found Paxlovid may not be as effective in all cases, with similar symptomatic durations in vaccinated high-risk and unvaccinated low-risk individuals.
www.scientificamerican.comhttps://www.scientificamerican.com/article/paxlovid-covid-treatment-most-beneficial-for-unvaccinated-people-with-risk/
While beneficial for older or immunocompromised individuals at high risk, Paxlovid may not provide symptom relief for those at low or moderate risk of severe infection.
www.scientificamerican.comhttps://www.scientificamerican.com/article/paxlovid-covid-treatment-most-beneficial-for-unvaccinated-people-with-risk/
Read at www.scientificamerican.com
#paxlovid #covid-treatment #effectiveness #risk-assessment #medical-research
[
|
]